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The spectrum of lipomatous lesions ranges from benign to highly malignant disease. Diﬀerentiation between these lesions is
important to indicate prognosis and choose the most appropriate treatment. Hemosiderotic ﬁbrohistiocytic lipomatous lesion
(HFLL) is a rare subtype of lipomatous tumor. The diagnosis is usually based on clinical, histological, and immunohistochemical
information. Where magnetic resonance (MR) imaging is a suitable modality to assess fatty tumors, no data is reported on MR
imaging of HFLL. Here, the MR characteristics are described in correlation with pathologic ﬁndings in a case of HFLL in the left
thigh, an unusual location.
Copyright © 2008 Ronald S. A. de Vreeze et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
The spectrum of lipomatous lesions ranges from benign to
highly malignant disease. Diﬀerentiation between these lesi-
ons is important to indicate prognosis and choose the most
appropriate treatment [1].
The hemosiderotic ﬁbrohistiocytic lipomatous lesion
(HFLL) is ﬁrst described by Marshall-Taylor in 2000 [2]. The
incidence of HFLL is estimated to be less than 0.2% of all
benign lipomatous lesions [2].
There is an ongoing debate about the resemblance of
early pleomorphic hyalinizing angiectatic tumor (PHAT)
and HFLL; some consider HFLL a precursor lesion of PHAT,
implicating HFLL to be a neoplastic lesion [3, 4], others
consider HFLL an individual more reactive lesion [5, 6].
Based on the cases described so far, HFLL is most
common in middle aged females, however there is a wide age
spectrum. HFLL is typically located on the distal extremities,
particularly on the dorsal side of the foot and may be
associated with venous stasis and trauma [3]. The median
size at clinical presentation is 50mm and ranges between 1
and 170mm [2, 5]. Surgical removal is mainstay treatment
for this lesion.
Local recurrences appear in approximately 50% of cases
and become apparent within one year [2, 5]. Distant metas-
tases have not been reported. Characteristic histopatholog-
ical features are the spindled cells morphology and the
presence of variably prominent hemosiderin pigment. The
most common immunoproﬁle is diﬀuse staining of the
spindled cell with CD34.
Previous data suggest that the appearance of lipomatous
tumors on magnetic resonance (MR) images is helpful in
establishing a diagnosis [7, 8]. To our knowledge, there are
no other reports describing the radiologic appearance of
HFLL. We report on the imaging features in correlation with
pathologic ﬁndings in a case of HFLL in the left thigh, an
unusual location.
2. CASE REPORT
A 66-year-old Caucasian man was sent to our tertiary
referral center for a lesion of the left thigh, nagging
pain, uncertain radiological diagnosis without histologic
diagnosis. The patient had noticed the lesion one and a half
year before and it had slowly increased in size. Besides oral
anticoagulation treatment for atrial ﬁbrillation, there was
no relevant medical history, speciﬁcally no trauma. Family
history was noncontributory. Physical examination revealed
a resistance involving half the anterior medial side of the
thigh. MR imaging was performed.2 Sarcoma
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Figure 1: Upper left transversal T1 (TR 545 TE 20) and fat saturated STIR image (TR 12000 TI 200 TE60) upper right, showing the thigh
and a homogenous lobulated mass. Coronal T1 and T2 weighted image is shown at the lower part of Figure 1, an image through left thigh
showing a homogenous mass with irregular boundaries.
MR imaging, by Philips 3T Achieva and intravenous
contrast series with Dotarem, showed a lipomatous lesion
of the left thigh measuring 19 × 8 × 4cm with irregu-
lar boundaries. The lesion showed multiple far reaching
intramuscular and subfascial extensions. The assessment
of internal structures showed a homogeneous, lobulated
lesion. Figure 1 illustrates the high signal intensity of the
lesion on T1- and T2 (STIR) weighted images with foci
of hyperintensity on the fat-saturated (STIR) images. The
signal intensity, particularly on T1 weighted images, was
substantially lower than that of surrounding subcutaneous
lipomatous tissue. Dynamic MR imaging was performed to
characterize the enhancement pattern of the tumor, which
showed homogeneous enhancement.
These combined imaging features were suggestive for a
benign lesion or low grade sarcoma. However, we could not
unequivocallydeﬁnetheseMRimagestoaspeciﬁcdiagnosis.
As intermediate or high grade sarcoma could not be ruled
out, and these lesions in our institute are preferably treated
bypreoperativeradiotherapy,atrucutbiopsywasperformed.
A thoracic computed tomography scan was made which did
not show distant metastasis.
Histopathological analysis did not allow a deﬁnitive
diagnosisandsuggestedanototherwiseclassiﬁablebenignor
low-grade lipomatous lesion; an intermediate or high-grade
liposarcoma was unlikely.
Basedontheseﬁndings,asurgicalresectionwasplanned.
The macroscopic aspect at surgery was a yellow-brown
fatty gelatinous lesion, 19cm in diameter, poorly circum-
scribed, unencapsulated and extending along muscles and
neurovascularstructures.Aresectionleavingnomacroscopic
residue (R1) was performed.Ronald S. A. de Vreeze et al. 3
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Figure 2: The upper left image shows the histology of HFLL. The upper right magniﬁed image shows the spindled cell component of HFLL,
whereas the inﬂammatory component of HFLL is shown in the lower left image, and macrophages with hemosiderin pigment (arrows) are
shown in both the lower images. In all illustrations, mature adipocytes are present.
3. HISTOPATHOLOGICAL ANALYSIS
After resection specimens were histopathologically evalu-
ated. Macroscopically, the unencapsulated lipomatous lesion
showed tissue that was darker yellow than the normal sur-
rounding fat. Microscopically, twenty representative samples
throughout the whole tumor were reviewed on hematoxylin-
eosin stained slides. In all of them, similar ﬁndings were
observed: the lesion demonstrated mature adipose tissue
with foci of proliferation of bland ﬂoret-, spindled-, and
giant- cell areas, extending along and between muscle ﬁbers.
A lobular appearance was created by various small wide
blood vessels associated with thin ﬁbrous septa. Around
these vessels, histiocytes, mast and plasma cells revealed
the inﬂammatory parts of this tumor. The nuclei of the
spindled and multinucleated cells varied in diameter, the
latter having a Touton giant cell-like character. Occasionally
larger nuclei were identiﬁed but without atypia, and very
sporadically mitoses were seen. Granular brown to golden
pigment and occasionally hyperchromatism was observed in
the interstitial space of tumor (see Figure 2).
Immunohistochemical analysis showed a notable stain-
ing primarily of the spindled cells and multinucleated cells
for CD34. S-100 was positive in mature fat cells. CD31,
PPARγ, and P53 were negative.
By combining histology and immunohistochemistry of
resected specimen with clinical information, the diagnosis
HFLL following Marshall-Taylor and Brown’s classiﬁcation
was established [2, 5].
4. DISCUSSION
The discrimination between the various diﬀerential diag-
noses of fatty tumors is generally based on clinical, imaging,
and histopathological features, sometimes combined with
immunohistochemical or molecular genetic features. Besides
clinical features suggesting malignancy, such as older age,
largesize,fastgrowth-rate,thereareMRfeaturesthatsuggest
malignancy. These include presence of nodular and/ or
globular or nonadipose mass-like areas and a decreased
percentage of fat composition. The percentage and analysis
of these nonfatty regions in these lipomatous tumors help
to distinguish between benign or malignant lesions. Further-
m o r e ,t w op r i o rs t u d i e si nl i p o m a t o u st u m o r sh a v ee m p h a -
sized that inﬁltrative margins may suggest the diagnosis of
benign lipomatous lesion rather than that of liposarcomas
[9, 10].
This case, unlike most described HFLL lesions, lacked a
historyofpriortrauma,presentedatanunusuallocationand
was large. However, the macroscopic aspect, morphological
and immunohistochemical features were consistent with
HFLL. The speciﬁc histological HFLL features could be
correlated to the MR characteristics. The fatty component of
the tumor was macroscopically darker brown than normal4 Sarcoma
fat tissue and correlated with lower signal intensity of the
HFLL compared to the surrounding subcutaneous fat. The
absence of a ﬁbrous capsule could be recognized with MR
ﬁndings as well as the wide intramuscular extension. The
internal tumor structures seen on MR imaging were a
reﬂection of the characteristic ﬁbrous bands in the overall
histological architecture. The spindled cell CD34 positive
areas were corresponding to the enhanced parts of the tumor
on the MR images. The abundant homogenous adipose
areas were reﬂecting on MR imaging in the lobulated areas.
The scarce speciﬁc iron deposition seen at histopathological
review however was not recognized on MR images or
dynamic gradient echo sequence, since the signal intensity
on MR was not decreased by iron deposition of HFLL.
Furthermore, the typical inﬂammatory parts of HFLL could
not be correlated with characteristic MR features.
Recently, Folpe and Weiss have proposed that early pleo-
morphic hyalinizing angietic tumorhasa presumedidentical
histology to HFLL [4]. Yet, the pathogenetic relationship
between these two lesions remains to be determined [3, 5, 6].
It must, however, be emphasized that general awareness of
HFLL allows physicians to reach a correct diagnosis. The
presence of only 26 HFLLs that have been histologically
described so far could be the main obstacle for physicians to
be aware of such lesions.
5. CONCLUSION
This report shows the MR images of an unusual case of
HFLL.
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